Coronavirus|Haryana Minister gets trial dosage of COVID-19 vaccine
Covaxin is being indigenously developed
Anil Vij being administered coronavirus vaccine Covaxin at Civil Health Center in Ambala on Friday.
Covaxin is being indigenously established
Haryana’s Health Minister Anil Vij was on Friday administered a trial dosage of prospective coronavirus vaccine Covaxin here, becoming the very first volunteer for the stage three trial of the vaccine throughout the nation.
The trial of Bharat Biotech’s Covaxin began in the State on Friday and the 67- year-old senior BJP leader was administered the dosage at the Civil Medical Facility at Ambala Cantt.
Mr. Vij stated he is the very first volunteer in the nation to take the dosage in stage 3 trial of the vaccine. He is mentioned to be the very first Cabinet Minister of any State government who has actually offered to take the trial dosage of a prospective vaccine against COVID-19
The MLA from Ambala Cantt. had on Wednesday stated the third stage of trial of Covaxin will start in the State on November 20 and had actually used to get immunized.
Covaxin is being established indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research. Human trials of Covaxin had begun at Rohtak’s Post Graduate Institute of Medical Sciences in July. A team of doctors from PGIMS, Rohtak, was present here, consisting of Vice-Chancellor O.P. Kalra and Dhruv Chaudhary.
Civil Cosmetic Surgeon (Ambala) Kuldeep Singh told press reporters that the Covaxin dosage was administrated to Mr. Vij successfully.
Earlier, the Minister underwent some tests at the health center where he was kept under observation for some time after being administered the vaccine. He later on also attended his workplace in Chandigarh.
Mr. Vij stated 1,000 volunteers will be signed up for COVID-19 vaccine screening in Haryana. He said that a team of medical professionals will periodically take a look at the volunteers on which the vaccine will be checked. On Bharat Biotech establishing the vaccine, Mr. Vij stated, “It is a matter of pride that the Indian company is making this vaccine against the disease which has struck the entire world.”
Medical professionals said they will now be keeping track of Mr. Vij over the next few months.
Last month, the vaccine maker stated it had successfully finished interim analysis of Stage 1 and 2 trials.
CLICK HERE TO FIND OUT MORE
( the headline, this story has actually not been published by Important India News staff and is released from a syndicated feed.).